Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
US News, Trends & Trusted Information
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.